[1] |
BORGHI C, AGABITI-ROSEI E, JOHNSON R J, et al. Hyperuricaemia and gout in cardiovascular,metabolic and kidney disease[J]. Eur J Intern Med, 2020, 80:1-11.
DOI
URL
|
[2] |
WANG C H, LUNDH M, FU A, et al. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice[J]. Sci Transl Med, 2020, 12(558):eaaz8664.
DOI
URL
|
[3] |
MASSILLO C, DUCA R B, LACUNZA E, et al. Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development[J]. Mol Oncol, 2020, 14(11):2868-2883.
DOI
URL
|
[4] |
HU C, JIA W. Multi-omics profiling:the way towards precision medicine in metabolic diseases[J]. J Mol Cell Biol, 2021. [Epub ahead of print]
|
[5] |
刘晓妮, 王颖, 李桃桃, 等. 2型糖尿病合并代谢综合征患者胰岛素抵抗指数与慢性炎症指标相关性研究[J]. 检验医学, 2019, 34(9):826-830.
|
[6] |
ULVEN S M, HOLVEN K B, RUNDBLAD A, et al. An isocaloric nordic diet modulates RELA and TNFRSF1A gene expression in peripheral blood mononuclear cells in individuals with metabolic syndrome-a SYSDIET sub-study[J]. Nutrients, 2019, 11(12):2932.
DOI
URL
|
[7] |
FRANCESCHI C, GARAGNANI P, PARINI P, et al. Inflammaging:a new immune-metabolic viewpoint for age-related diseases[J]. Nat Rev Endocrinol, 2018, 14(10):576-590.
DOI
|
[8] |
CAI J, XU M, ZHANG X, et al. Innate immune signaling in nonalcoholic fatty liver disease and cardiovascular diseases[J]. Annu Rev Pathol, 2019, 14:153-184.
DOI
PMID
|
[9] |
DARYABOR G, ATASHZAR M R, KABELITZ D, et al. The effects of type 2 diabetes mellitus on organ metabolism and the immune system[J]. Front Immunol, 2020, 11:1582.
DOI
PMID
|
[10] |
KEWCHAROENWONG C, SAENWONGSA W, WILLCOCKS S J, et al. Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection[J]. Tuberculosis (Edinb), 2020, 123:101939.
DOI
URL
|
[11] |
SCHNEIDER-MATYKA D, SZKUP M, OWCZAREK A J, et al. The relationship between the IFNG (rs2430561) polymorphism and metabolic syndrome in perimenopausal women[J]. Medicina (Kaunas), 2020, 56(8):384.
|
[12] |
JAISWAL N, AGRAWAL S, AGRAWAL A. High fructose-induced metabolic changes enhance inflammation in human dendritic cells[J]. Clin Exp Immunol, 2019, 197(2):237-249.
DOI
PMID
|
[13] |
LIU J, GUO Z, ZHANG Y, et al. LCK inhibitor attenuates atherosclerosis in ApoE-/- mice via regulating T cell differentiation and reverse cholesterol transport[J]. J Mol Cell Cardiol, 2020, 139:87-97.
DOI
URL
|
[14] |
LIN W, LIU H, TANG Y, et al. The development and controversy of competitive endogenous RNA hypothesis in non-coding genes[J]. Mol Cell Biochem, 2021, 476(1):109-123.
DOI
|
[15] |
DOLATI S, SHAKOURI S K, DOLATKHAH N, et al. The role of exosomal non-coding RNAs in aging-related diseases[J]. Biofactors, 2021, 47(3):292-310.
DOI
PMID
|
[16] |
ORTIZ-DOSAL A, RODIL-GARCÍA P, SALAZAR-OLIVO L A. Circulating microRNAs in human obesity:a systematic review[J]. Biomarkers, 2019, 24(6):499-509.
DOI
URL
|
[17] |
HUANG Y, ZHAO L, YAN Y, et al. PBMCs to stress-associated miR-18a-5p and miR-22-3p ratios as new indicators of metabolic syndrome[J]. Biomed Res Int, 2020, 2020:8159342.
|
[18] |
BROZZI F, REGAZZI R. Circular RNAs as novel regulators of β-cell functions under physiological and pathological conditions[J]. Int J Mol Sci, 2021, 22(4):1503.
DOI
URL
|
[19] |
ZAIOU M. Circular RNAs as potential biomarkers and therapeutic targets for metabolic diseases[J]. Adv Exp Med Biol, 2019, 1134:177-191.
DOI
PMID
|